Virax Biolabs Group (VRAX) Stock Chart & Stock Price History $2.04 -0.03 (-1.45%) (As of 11/1/2024 ET) Add Compare Share Share Chart Stock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Virax Biolabs Group Stock Price Performance5 Day Performance-7.69%1 Month Performance+10.27%3 Month Performance+80.53%6 Month Performance+234.43%Year-To-Date Performance+39.73%1 Year Performance-21.54% Receive VRAX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Virax Biolabs Group and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyTrue paradigm shiftI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. VRAX Stock Chart for Saturday, November, 2, 2024 VRAX Chart by TradingView Virax Biolabs Group Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/01/2024$2.07$2.04-1.45%$2.17$2.02173,959 shs$6.59 million10/31/2024$2.24$2.07-7.59%$2.29$2.03283,353 shs$6.69 million10/30/2024$2.18$2.24+2.75%$2.48$2.13603,463 shs$7.24 million10/29/2024$2.21$2.18-1.36%$2.29$2.13341,142 shs$7.04 million10/28/2024$2.28$2.21-3.07%$2.34$2.16273,536 shs$7.14 million10/25/2024$2.57$2.28-11.28%$2.55$2.16769,364 shs$7.36 million Get the Latest News and Ratings for VRAX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Virax Biolabs Group and its competitors with MarketBeat's FREE daily newsletter. 10/24/2024$2.52$2.57+1.98%$2.80$2.252.77 million shs$8.30 million10/23/2024$1.68$2.52+50.00%$3.62$2.3689.93 million shs$3.92 million10/22/2024$1.63$1.68+3.07%$1.89$1.66506,510 shs$5.43 million10/21/2024$1.53$1.63+6.54%$1.69$1.50247,389 shs$5.27 million10/18/2024$1.56$1.53-1.92%$1.59$1.46120,474 shs$4.94 million10/17/2024$1.61$1.56-3.11%$1.61$1.48213,133 shs$5.04 million10/16/2024$1.70$1.61-5.29%$1.68$1.59176,844 shs$5.20 million10/15/2024$1.81$1.70-6.08%$1.84$1.68155,246 shs$2.64 million10/14/2024$1.79$1.81+1.12%$1.93$1.79109,835 shs$5.85 million10/11/2024$1.79$1.79$1.82$1.69103,924 shs$2.78 million10/10/2024$1.79$1.79$1.86$1.72134,036 shs$5.78 million10/09/2024$1.71$1.79+4.68%$1.87$1.67280,207 shs$5.78 million10/08/2024$1.76$1.71-2.84%$1.90$1.70311,033 shs$5.52 million10/07/2024$1.94$1.76-9.28%$1.92$1.75136,336 shs$5.69 million10/04/2024$1.95$1.94-0.51%$2.04$1.81243,634 shs$6.27 million10/03/2024$1.85$1.95+5.41%$2.06$1.77430,507 shs$6.30 million10/02/2024$1.62$1.85+14.20%$2.17$1.531.72 million shs$5.98 million10/01/2024$1.94$1.62-16.49%$1.96$1.59462,682 shs$5.23 million09/30/2024$1.94$1.94$2.00$1.88235,120 shs$6.27 million09/27/2024$1.93$1.94+0.52%$2.01$1.89247,066 shs$6.27 million09/26/2024$1.99$1.93-3.02%$2.04$1.88364,974 shs$6.23 million09/25/2024$1.93$1.99+3.11%$2.04$1.84319,891 shs$3.09 million09/24/2024$2.23$1.93-13.45%$2.25$1.93945,097 shs$3.00 million09/23/2024$2.44$2.23-8.61%$2.51$2.22421,840 shs$3.47 million09/20/2024$2.53$2.44-3.56%$2.56$2.44552,946 shs$7.88 million09/19/2024$2.69$2.53-5.95%$2.69$2.46858,478 shs$8.17 million09/18/2024$2.87$2.69-6.27%$2.92$2.68314,248 shs$8.69 million09/17/2024$2.84$2.87+1.06%$3.02$2.531.26 million shs$4.46 million09/16/2024$2.59$2.84+9.65%$3.55$2.6814.76 million shs$4.42 million09/13/2024$2.63$2.59-1.52%$2.66$2.40485,190 shs$8.37 million09/12/2024$2.99$2.63-12.04%$2.95$2.621.11 million shs$4.09 million09/11/2024$3.00$2.99-0.33%$3.26$2.921.03 million shs$4.65 million09/10/2024$3.19$3.00-5.96%$3.18$2.84856,738 shs$9.69 million09/09/2024$3.51$3.19-9.12%$3.50$3.17812,545 shs$10.30 millionTrue paradigm shift (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you.09/06/2024$4.03$3.51-12.90%$4.26$3.511.51 million shs$11.34 million09/05/2024$3.96$4.03+1.77%$4.44$3.801.87 million shs$13.02 million09/04/2024$4.55$3.96-12.97%$4.44$3.961.10 million shs$12.79 million09/03/2024$4.66$4.55-2.36%$4.93$4.131.66 million shs$14.70 million09/02/2024$4.66$4.66$5.52$4.632.17 million shs$15.05 million08/30/2024$5.06$4.66-7.91%$5.52$4.632.14 million shs$7.22 million08/29/2024$4.87$5.06+3.90%$5.54$4.304.81 million shs$7.84 million08/28/2024$4.89$4.87-0.41%$7.63$4.8067.66 million shs$7.55 million08/27/2024$4.61$4.89+6.07%$4.92$4.321.53 million shs$7.58 million08/26/2024$5.45$4.61-15.41%$5.29$4.204.10 million shs$7.15 million08/23/2024$5.18$5.45+5.21%$6.22$5.207.48 million shs$8.45 million08/22/2024$6.40$5.18-19.06%$6.75$4.8810.99 million shs$8.03 million08/21/2024$3.56$6.40+79.78%$6.40$3.2946.99 million shs$9.92 million08/20/2024$5.15$3.56-30.87%$4.40$3.563.96 million shs$5.52 million08/19/2024$2.13$5.15+141.78%$9.00$4.3194.03 million shs$8.01 million08/16/2024$1.39$2.13+53.24%$2.30$1.407.65 million shs$3.30 million08/15/2024$1.73$1.39-19.65%$1.64$1.331.43 million shs$2.16 million08/14/2024$1.28$1.73+35.16%$1.90$1.183.98 million shs$2.68 million08/13/2024$1.35$1.28-5.19%$1.35$1.22164,263 shs$1.98 million08/12/2024$1.16$1.35+16.38%$1.43$1.10146,210 shs$2.09 million08/09/2024$1.08$1.16+7.41%$1.18$1.05219,096 shs$1.80 million08/08/2024$1.09$1.08-0.92%$1.11$1.0526,950 shs$1.67 million08/07/2024$1.03$1.09+5.83%$1.17$1.00285,075 shs$1.70 million08/06/2024$1.05$1.03-1.90%$1.17$0.9941,254 shs$1.60 million08/05/2024$1.13$1.05-7.08%$1.35$0.97339,020 shs$1.63 million08/02/2024$1.15$1.13-1.74%$1.30$1.10229,213 shs$1.75 million08/01/2024$1.25$1.15-7.63%$1.65$1.11356,411 shs$1.78 million Related Companies Acurx Pharmaceuticals Stock Chart Lakeshore Biopharma Stock Chart Eyenovia Stock Chart MiNK Therapeutics Stock Chart ImmuCell Stock Chart Tempest Therapeutics Stock Chart KALA BIO Stock Chart Flora Growth Stock Chart Bright Green Stock Chart iBio Stock Chart Receive VRAX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Virax Biolabs Group and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VRAX) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredThe Final FrontierAnd a lot of powerful investors would rather this exposé never saw the light of day. I suspect they’ll attempt...Porter & Company | SponsoredWall St. Legend: Millions of Americans About to Fall Out of the 1%Wall Street insider reveals the financial tidal wave about to knock millions of Americans out of the One Perce...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virax Biolabs Group Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Virax Biolabs Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
